Keyphrases
Older Adults
95%
Physical Function
94%
Interleukin-6
84%
Mouse Model
79%
Frailty
77%
Cognitive Function
68%
Physical Decline
49%
Chronic Inflammation
48%
Aging
45%
Inflammatory Markers
44%
Mitochondrial Dysfunction
44%
Frailty Assessment
39%
Nanofilaments
39%
Humanized
39%
Community-dwelling Older Adults
39%
Sacubitril
39%
Cognitive Outcome
39%
Dementia Risk
39%
Targeted Deletion
39%
Frail Elderly
39%
Vulnerability
39%
Preoperative Evaluation
39%
Genomic DNA (gDNA)
39%
Knock-in Mouse Model
39%
Postoperative Outcomes
39%
Cytokine Storm
39%
COVID-19 Outcomes
39%
Aging Immune System
39%
Cell-free Mitochondrial DNA
39%
Physical Outcomes
39%
Circulating Cell-free
39%
Alzheimer's Disease
39%
Alzheimer's Disease Prevention
39%
Erectile Dysfunction Medication
39%
Repurposing
39%
Inflammatory Pathways
35%
Innate Immune Response
29%
Adverse Health Outcomes
25%
Age-related
24%
Brain Renin-angiotensin System
23%
Dementia
22%
Higher Level of Care
19%
Randomized Controlled Trial
19%
Health Measures
19%
Length of Hospital Stay
19%
Chronic Disease Prevalence
19%
Complex Field
19%
Self-report Measures
19%
Disease States
19%
Age-related Changes
19%
Medicine and Dentistry
Frailty
100%
Interleukin 6
44%
Mitochondrial DNA
39%
Community-Dwelling Older Adults
39%
Preoperative Evaluation
39%
Cytokine Storm
39%
Innate Immunity
39%
Immune System
39%
Genomic DNA
39%
COVID-19
39%
Erectile Dysfunction
39%
Drug Therapy
39%
Prophylaxis
39%
Alzheimer's Disease
39%
Cell-Free DNA
29%
Chronic Disease
26%
Health Outcomes
26%
Prevalence
26%
Skeletal Muscle
18%
Cell Death
18%
DNA Fragment
17%
Cognition
14%
Muscle Tissue
13%
Drive
13%
Pathophysiology
13%
Adaptive Immunity
13%
Brain Tissue
13%
Inflammatory Mediator
13%
Cardiovascular System
13%
Infection
13%
Necrosis
13%
Patient Monitoring
13%
Interleukin-6
11%
2 Butyl 4 Chloro 1 [[2' (1h Tetrazol 5 Yl) 4 Biphenylyl]methyl] 5 Imidazolecarboxylic Acid
11%
Decision Making
9%
Adverse Outcome
9%
Polymerase Chain Reaction
9%
Randomized Controlled Trial
9%
Homeostasis
9%
Surgery
9%
Cognitive Defect
9%
Postoperative Complication
9%
Surgeon
9%
Walking Speed
9%
Geriatric Syndrome
9%
Anesthesiologist
9%
Chronic Inflammation
8%
Social Health
6%
Patient with Alzheimer's Disease
6%
Amyloid Protein
6%
Neuroscience
Angiotensin Receptor
77%
Eicosanoid Receptor
74%
Alzheimer's Disease
71%
Angiotensin
68%
Oxidative Stress
61%
Angiotensin II Receptor Type 1
59%
Cognitive Disorders
53%
Interleukin 6
44%
Losartan
39%
Mitochondrial DNA
39%
Renin
37%
Receptor Subtype
31%
Angiotensin II
28%
Amyloid
21%
Acetylcholine Release
18%
Dopamine Release
18%
DNA Fragment
17%
Endocrine System
13%
Necrosis
13%
Neurodegenerative Disorder
13%
Intracrine
13%
Neurotransmitter
13%
Memory Consolidation
13%
Parkinson's Disease
13%
Placebo
11%
Frontal Lobe
10%
Cell Death
8%
Agonist
5%
Mitophagy
5%
Mitochondrial Biogenesis
5%
Peroxisome Proliferator-Activated Receptor Gamma
5%
Cell Proliferation
5%
Metabolic Pathway
5%
Energy Transfer
5%
Antihypertensive Agent
5%
Skeletal Muscle
5%